Scientists have discovered a new medicine that they say offers hope of substantially slowing the progress of motor neurone disease (MND).
The drug, named M102, works by protecting nerve cells damaged by MND.
Preclinical studies of…

Scientists have discovered a new medicine that they say offers hope of substantially slowing the progress of motor neurone disease (MND).
The drug, named M102, works by protecting nerve cells damaged by MND.
Preclinical studies of…

The cholesterol medication alirocumab, a PCSK9 inhibitor, combined with a statin appeared to reduce LDL cholesterol levels by more than 50% among patients after a heart transplant, according to a late-breaking science presentation…

New research from Intermountain Health in Salt Lake City finds that patients diagnosed with peripheral arterial disease (PAD) who also have atrial fibrillation (AFib) face a significantly higher risk of major adverse cardiovascular…

Eczema is a common skin condition that causes itching, redness, and irritation, affecting people of all ages. It can appear anywhere on the body and often follows cycles of flare-ups and calm periods. While generally not serious, eczema can…

New data from the Office for National Statistics shows that more people in Britain now use e-cigarettes than smoke traditional cigarettes, for the first time.
The Independent reported on new statistics from the British government,…

Adherence to immunosuppressant medication is essential for achieving successful outcomes in graft-vs-host disease (GVHD) management after allogeneic stem cell transplantation (alloSCT). Tacrolimus, the key immunosuppressant, has a narrow…

Kevin KeaneScotland environment, energy and rural affairs correspondent
Getty ImagesScottish scientists in the Amazon are helping to tackle a growing threat from vampire bats, which…